BIT
ABUS icon

BlackRock Institutional Trust’s Arbutus Biopharma ABUS Stock Holding History

BlackRock Institutional Trust’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,886
Closed -$13K – 3826
2016
Q3 		$13K Buy
+3,886
New +$15.2K ﹤0.01% 3828
2015
Q2 		– Sell
-379
Closed -$7K – 3907
2015
Q1 		$7K Sell
379
-7,837
-95% -$161K ﹤0.01% 3825
2014
Q4 		$124K Buy
8,216
+2,416
+42% +$41.7K ﹤0.01% 3695
2014
Q3 		$123K Sell
5,800
-6,471
-53% -$106K ﹤0.01% 3662
2014
Q2 		$160K Buy
12,271
+3,653
+42% +$51.8K ﹤0.01% 3723
2014
Q1 		$185K Buy
+8,618
New +$155K ﹤0.01% 3711

Other funds holding ABUS

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

BlackRock Institutional Trust's ABUS Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of Arbutus Biopharma (ABUS) in Q4 2016, closing a stake of 3,886 shares — an estimated $13K sold.

BlackRock Institutional Trust first reported a position in ABUS in Q1 2014 and held it in 6 quarters. The position peaked at $185K in Q1 2014. 55 funds tracked by Wall St. Rank hold ABUS as of Q4 2016.

  • BlackRock Institutional Trust reported no remaining Arbutus Biopharma position as of Q4 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 3,886 Arbutus Biopharma shares in Q4 2016, an estimated $13K.
  • BlackRock Institutional Trust first reported a position in Arbutus Biopharma in Q1 2014 and held it in 6 quarters.
  • BlackRock Institutional Trust's Arbutus Biopharma position peaked at $185K in Q1 2014.
  • 55 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.